RVMD Stock Price
Revolution Medicines, Inc.
RVMD stock price is $193.99 (+2.95% on the day), giving Revolution Medicines, Inc. a market cap of $40.39B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
RVMD Stock Overview
- Price
- $193.99
- Previous close
- $188.44
- Open
- $186.84
- Market cap
- $40.39B
- P/E ratio
- -35.7
- 52-week range
- $47.45 - $224.31
- 1-year price target
- $253.00
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NGS
- MarketXLS Rank
- 35
About Revolution Medicines, Inc.
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline includes RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; and RMC-5552, which is in phase 1 clinical trial. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RVMD | $193.99 | +2.9% | 1.42M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Revolution Medicines, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW